The Breast International Group (BIG) is an international non-profit organisation for academic breast cancer research groups from around the world.
By encouraging interaction and cooperation between its members and other academic networks, BIG’s mission is to facilitate the conduct of large and difficult breast cancer clinical trials and to reduce the wasteful duplication of efforts.
BIG is a “communications network” that enables its members to get together in an organised way to discuss and establish research priorities together and draw on their combined resources to achieve study results in a fast, efficient manner while ensuring the highest standards of research.
BIG also serves as coordinator for the TRANSBIG consortium for translational research.
Click here to access the BIG website. |
TRANSBIG is a translational research network of 39 world-class institutions in 21 countries managed by the BIG-TRANSBIG Secretariat in Brussels.
The key to individualising treatment for cancer lies in finding a way to quickly “translate” the discoveries about human genetics made by laboratory scientists into tools that physicians can use to help make decisions about the way they treat patients. TRANSBIG is devoted specifically to this type of research in breast cancer.
TRANSBIG was created to improve high-level collaboration by bringing together organisations with expertise that range from specialisation in cutting-edge biomedical technologies to patient representation.
TRANSBIG’s first project is a clinical trial called MINDACT (“Microarray for Node Negative Disease may Avoid Chemotherapy”).
Click here to access the TRANSBIG website.
|